CCL19 and atherosclerosis: The upregulation of key proteins such as IL-6, CXCL10, and CCL19 suggests an inflammatory signature in OBO individuals that may promote atherosclerosis along with other upregulated pro-inflammatory cytokines activating monocytes (Supplementary Figure S1C).